PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22627197 ↗2012Reported benefit

Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.

RatIschaemia-reperfusionCerebral (MCAO/stroke)Sprague-DawleyMale5 mg/kg acute; 2.5 mg/kg subchronicAcute treatment at the time of ischemia; subchronic treatment continued for 7 d…

Model: Middle cerebral artery occlusion for 1 h followed by reperfusion

Acute 5 mg/kg and subchronic 2.5 mg/kg ziprasidone significantly reduced infarct size versus vehicle. Acute treatment improved neurological function dose-dependently, and subchronic treatment gave more rapid recovery from functional deficits, prevented severe loss of neuronal marker intensity and a…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.78. Machine-extracted fields require source verification.